| 产品描述: | Ex26 (S1P1-IN-Ex26) 是一种强效和选择性的 sphingosine 1-phosphate receptor 1 (S1P1) 拮抗剂 (IC50=0.93 nM),对 S1P1 的选择性大于其他 Sphingosine 1-phosphate receptor 约 3,000 倍。Ex26 可用于实验性自身免疫性脑脊髓炎的研究。 |
| 靶点: |
IC50: 0.93 nM (S1P1) |
| 体外研究: |
Ex26 (0-10 μM; 1 h) treatment shows excellent selectivity for S1P1 over other Sphingosine 1-phosphate receptors. |
| 体内研究: |
Ex26 (i.p.; 3 mg/kg; once daily; 3 d) treatment disrupts S1P1 signaling inhibiting the lymphocyte and thymocyte egress. Ex26 (i.p.; 30 mg/kg; once daily; 15 d) treatment alleviates experimental autoimmune encephalomyelitis by S1P1 antagonism. |
| 参考文献: |
1. Stuart M Cahalan, et al. Sphingosine 1-phosphate receptor 1 (S1P(1)) upregulation and amelioration of experimental autoimmune encephalomyelitis by an S1P(1) antagonist. Mol Pharmacol. 2013 Feb;83(2):316-21. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.02 ml |
10.101 ml |
20.203 ml |
| 5 mM |
0.404 ml |
2.02 ml |
4.041 ml |
| 10 mM |
0.202 ml |
1.01 ml |
2.02 ml |
| 50 mM |
0.04 ml |
0.202 ml |
0.404 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |